首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
N1 - ((PYRAZOL-1-YMETHYL) -2-METHYLPHENYL)- PHATALAMIDE DERIVATIVES AND RELATED COMPOUNDS INSECTICIDES
摘要
申请公布号
EP1727804(A1)
申请公布日期
2006.12.06
申请号
EP20050731064
申请日期
2005.03.01
申请人
BAYER CROPSCIENCE AKTIENGESELLSCHAFT
发明人
WADA, KATSUAKI;GOMIBUCHI, TAKUYA;YONETA, YASUSHI;OTSU, YUICHI;SHIBUYA, KATSUHIKO;NAKAKURA, NORIHIKO;FISCHER, RUEDIGER;SHIMOJO, EIICHI;MURATA, TETSUYA
分类号
C07D231/16;A01N43/36;A01N43/54;A01N43/56;A01N43/653;A01N43/78;C07D207/32;C07D207/333;C07D231/08;C07D231/12;C07D231/18;C07D231/20;C07D233/54;C07D233/68;C07D239/30;C07D249/08;C07D249/12
主分类号
C07D231/16
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Device for controlling a component of an electronic board and activation system comprising same
Device for releasing a self-expanding stent into a body vessel
Reverse voltage protected integrated circuit arrangement
SELF-CLEANING INJECTION PORT FOR ANALYTICAL APPLICATIONS
PHOTOGRAPHING SYSTEM AND PHOTOGRAPHING METHOD
TYPE II PHASE LOCKED LOOP USING DUAL PATH AND DUAL VARACTORS TO REDUCE LOOP FILTER COMPONENTS
SYSTEMS AND METHODS FOR EMPHASIZED CYTOLOGICAL SPECIMEN REVIEW
OCCUPANT RESTRAINT DEVICE FOR A MOTOR VEHICLE
Voltage-controlled oscillator with stable gain over a wide frequency range
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
Ink-jet printer
Pharmaceutical compositions comprising a calcilytic agent
SEMICONDUCTOR BODY, CIRCUIT ARRANGEMENT HAVING THE SEMICONDUCTOR BODY AND METHOD
MOBILE COMMUNICATION TERMINAL DEVICE, METHOD OF DISPLAYING FUNCTION MENU USED FOR THE SAME AND ITS PROGRAM
SINGLE-SIDED CIRCUIT BOARD AND METHOD FOR MANUFACTURING THE SAME
Compliant pin strip with integrated dam bar
CHANGING A SCHEDULER IN A VIRTUAL MACHINE MONITOR
AN OPTICAL COMMUNICATION SYSTEM FOR WIRELESS RADIO SIGNALS
Portable computer device, method and computer program product
OXIDIZED PROTEINS, THEIR BIOLOGICAL ACTIVITY, AND THERAPEUTIC AND DIAGNOSTIC MEASURES, WHICH ARE DERIVED FROM THE ACTIVE MECHANISM, FROM THE USE OF THESE PROTEINS OR FROM THE INHIBITION THEREOF